TNF receptor 2 pathway: drug target for autoimmune diseases

An endotoxin-induced serum factor that causes necrosis of tumors

Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N., & Williamson, B. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.9.3666 · Cited by 4,532 · see citing works

Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis

Lipsky, P. E., van der Heijde, D. M. F. M., Clair, E. W. S., Fürst, D. E., Breedveld, F. C., Kalden, J. R., Smolen, J. S., Weisman, M. H., Emery, P., Feldmann, M., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011303432202 · Cited by 2,990 · see citing works

Signalling pathways of the TNF superfamily: a double-edged sword

Aggarwal, B. B. (2003) · Nature Reviews Immunology · doi:10.1038/nri1184 · Cited by 2,793 · see citing works

Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes

Micheau, O., & Tschopp, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00521-x · Cited by 2,738 · see citing works

ROLE OF CYTOKINES IN RHEUMATOID ARTHRITIS

Feldmann, M., Brennan, F. M., & Maini, R. N. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.397 · Cited by 2,486 · see citing works

The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation

Hsu, H., Xiong, J., & Goeddel, D. V. (1995) · Cell · doi:10.1016/0092-8674(95)90070-5 · Cited by 2,024 · see citing works

Tumour necrosis factor and cancer

Balkwill, F. R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2628 · Cited by 1,925 · see citing works

The PREMIER study: A multicenter, randomized, double‐blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment

Breedveld, F. C., Weisman, M. H., Kavanaugh, A. F., Cohen, S. B., Pavelká, K., van Vollenhoven, R., Sharp, J. T., Perez, J. L., & Spencer-Green, G. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21519 · Cited by 1,786 · see citing works

Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial

Klareskog, L., van der Heijde, D., de Jager, J. P., Gough, A., Kalden, J., Malaise, M., Mola, E. M., Pavelka, K., Sany, J., Settas, L., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15640-7 · Cited by 1,751 · see citing works

Etanercept Therapy in Rheumatoid Arthritis

Moreland, L. W., Schiff, M. H., Baumgartner, S. W., Tindall, E. A., Fleischmann, R. M., Bulpitt, K. J., Weaver, A. L., Keystone, E. C., Furst, D. E., Mease, P. J., et al. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00004 · Cited by 1,403 · see citing works

The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor

Grell, M., Douni, E. K., Wajant, H., Löhden, M., Clauss, M. A., Maxeiner, B., Georgopoulos, S., Lesslauer, W., Kollias, G. A., Pfizenmaier, K., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90192-2 · Cited by 1,328 · see citing works

A novel domain within the 55 kd TNF receptor signals cell death

Tartaglia, L. A., Ayres, T. M., Wong, G. H., & Goeddel, D. V. (1993) · Cell · doi:10.1016/0092-8674(93)90464-2 · Cited by 1,290 · see citing works

Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus

Herold, K. C., Hagopian, W., Auger, J. A., Poumian-Ruiz, E., Taylor, L., Donaldson, D., Gitelman, S. E., Harlan, D. M., Xu, D., Zivin, R. A., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012864 · Cited by 1,222 · see citing works

INFLIXIMAB AND METHOTREXATE IN THE TREATMENT OF RHEUMATOID ARTHRITIS

Ipsky, P. E. E. L., Illiam, E. W., Urst, D. A. E. F., Reedveld, C. B., Oachim, J., Alden, R. K., Osef, J., Molen, S. S., Eisman, M. I. W., Mery, P. A. E., et al. (2000) · Cited by 1,155 · see citing works

Induction of apoptosis in mature T cells by tumour necrosis factor

Zheng, L., Fisher, G. H., Miller, R. E., Peschon, J. J., Lynch, D. H., & Lenardo, M. J. (1995) · Nature · doi:10.1038/377348a0 · Cited by 1,116 · see citing works

Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes

Keymeulen, B., Vandemeulebroucke, E., Ziegler, A. G., Mathieu, C., Kaufman, L., Hale, G., Gorus, F., Goldman, M., Walter, M., Candon, S., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043980 · Cited by 1,099 · see citing works

A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor

Rothe, M., Wong, S. C., Henzel, W. J., & Goeddel, D. V. (1994) · Cell · doi:10.1016/0092-8674(94)90532-0 · Cited by 1,054 · see citing works

TRAF2-Mediated Activation of NF-κB by TNF Receptor 2 and CD40

Rothe, M., Sarma, V. J., Dixit, V. M., & Goeddel, D. V. (1995) · Science · doi:10.1126/science.7544915 · Cited by 1,050 · see citing works

lnterleukin-2 programs mouse αβ T lymphocytes for apoptosis

Lenardo, M. J. (1991) · Nature · doi:10.1038/353858a0 · Cited by 1,021 · see citing works

TNFα promotes proliferation of oligodendrocyte progenitors and remyelination

Arnett, H. A., Mason, J., Marino, M., Suzuki, K., Matsushima, G. K., & Ting, J. P.-Y. (2001) · Nature Neuroscience · doi:10.1038/nn738 · Cited by 1,012 · see citing works

The role of TNF superfamily members in T-cell function and diseases

Croft, M. (2009) · Nature reviews. Immunology · doi:10.1038/nri2526 · Cited by 924 · see citing works

Circuitry of nuclear factor κB signaling

Hoffmann, A., & Baltimore, D. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00375.x · Cited by 907 · see citing works

Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial

Chaudhari, U., Romano, P., Mulcahy, L., Dooley, L. T., Dg, B., & Gottlieb, A. B. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04954-0 · Cited by 888 · see citing works

TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease

McCoy, M. K., & Tansey, M. G. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-45 · Cited by 843 · see citing works

NOD2 is a negative regulator of Toll-like receptor 2–mediated T helper type 1 responses

Watanabe, T., Kitani, A., Murray, P. J., & Strober, W. (2004) · Nature Immunology · doi:10.1038/ni1092 · Cited by 839 · see citing works

<i>TRAF1–C5</i> as a Risk Locus for Rheumatoid Arthritis — A Genomewide Study

Plenge, R. M., Seielstad, M., Padyukov, L., Lee, A. T., Remmers, E. F., Ding, B., Liew, A., Khalili, H., Chandrasekaran, A., Davies, L. R. L., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa073491 · Cited by 823 · see citing works

The two different receptors for tumor necrosis factor mediate distinct cellular responses.

Tartaglia, L. A., Weber, R. F., Figari, I. S., Reynolds, C. P., Palladino, M. A., & Goeddel, D. V. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.20.9292 · Cited by 792 · see citing works

Nod2 Mutation in Crohn's Disease Potentiates NF-κB Activity and IL-1ß Processing

Maeda, S., Hsu, L.-C., Liu, H., Bankston, L. A., Iimura, M., Kagnoff, M. F., Eckmann, L., & Karin, M. (2005) · Science · doi:10.1126/science.1103685 · Cited by 748 · see citing works

A Single Course of Anti-CD3 Monoclonal Antibody hOKT3γ1(Ala-Ala) Results in Improvement in C-Peptide Responses and Clinical Parameters for at Least 2 Years after Onset of Type 1 Diabetes

Herold, K. C., Gitelman, S. E., Masharani, U. B., Hagopian, W., Bisikirska, B. C., DONALDSON, D. L., Rother, K. I., Diamond, B. E., Harlan, D. M., & Bluestone, J. A. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1763 · Cited by 631 · see citing works

Small-Molecule Inhibition of TNF-α

He, M. M., Stroustrup, A., Oslob, J. D., Flanagan, W. M., Braisted, A. C., Whitty, A., Cancilla, M. T., Wang, J., Lugovskoy, A. A., Yoburn, J. C., et al. (2005) · Science · doi:10.1126/science.1116304 · Cited by 626 · see citing works

Neurodegenerative and Neuroprotective Effects of Tumor Necrosis Factor (TNF) in Retinal Ischemia: Opposite Roles of TNF Receptor 1 and TNF Receptor 2

Fontaine, V. K., Mohand‐Saïd, S., Hanoteau, N., Fuchs, C., Pfizenmaier, K., & Eisel, U. L. M. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-07-j0001.2002 · Cited by 587 · see citing works

Death receptor signal transducers: nodes of coordination in immune signaling networks

Wilson, N., Dixit, V., & Ashkenazi, A. (2009) · Nature Immunology · doi:10.1038/ni.1714 · Cited by 569 · see citing works

TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2

Li, X., Yang, Y., & Ashwell, J. D. (2002) · Nature · doi:10.1038/416345a · Cited by 452 · see citing works

Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library

Wong, F. S., Karttunen, J. T., Dumont, C., Li, W., Visintin, I., Pilip, I. M., Shastri, N., Pamer, E. G., & Janeway, C. A. (1999) · Nature Medicine · doi:10.1038/12465 · Cited by 427 · see citing works

Adoptive Transfer of Diabetes Into Immunodeficient NOD-scid/scid Mice: Relative Contributions of CD4+ and CD8+ T-Cells From Diabetic Versus Prediabetic NOD.NON-Thy-1a Donors

Christianson, S. W., Shultz, L. D., & Leiter, E. H. (1993) · Diabetes · doi:10.2337/diab.42.1.44 · Cited by 427 · see citing works

Tumor Necrosis Factor (TNF)-mediated Neuroprotection against Glutamate-induced Excitotoxicity Is Enhanced by N-Methyl-D-aspartate Receptor Activation

Marchetti, L., Klein, M., Schlett, K., Pfizenmaier, K., & Eisel, U. L. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311766200 · Cited by 424 · see citing works

The RIP kinases: crucial integrators of cellular stress

Meylan, E., & Tschopp, J. (2005) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2005.01.003 · Cited by 383 · see citing works

Antibodies to a soluble form of a tumor necrosis factor (TNF) receptor have TNF-like activity.

Engelmann, H., Holtmann, H., Brakebusch, C., Avni, Y. S., SAROV, I., Nophar, Y., Hadas, E., Leitner, O., & Wallach, D. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)77330-4 · Cited by 374 · see citing works

The Crohn's Disease Protein, NOD2, Requires RIP2 in Order to Induce Ubiquitinylation of a Novel Site on NEMO

Abbott, D. W., Wilkins, A., Asara, J. M., & Cantley, L. C. (2004) · Current Biology · doi:10.1016/j.cub.2004.12.032 · Cited by 374 · see citing works

Tissue Expression and Immunolocalization of Tumor Necrosis Factor-α in Postinfarction Dysfunctional Myocardium

Irwin, M. W., Mak, S. S., Mann, D. L., Qu, R., Penninger, J. M., Yan, A. T.-K., Dawood, F., Wen, W.-H., Shou, Z., & Liu, P. J. (1999) · Circulation · doi:10.1161/01.cir.99.11.1492 · Cited by 368 · see citing works

Islet Regeneration During the Reversal of Autoimmune Diabetes in NOD Mice

Kodama, S., Kühtreiber, W. M., Fujimura, S., Dale, E. A., & Faustman, D. L. (2003) · Science · doi:10.1126/science.1088949 · Cited by 356 · see citing works

The Pittsburgh Insulin-dependent Diabetes Mellitus (IDDM) Morbidity and Mortality Study: Mortality Results

Dorman, J. S., LaPorte, R. E., Kuller, L. H., Cruickshanks, K. J., Orchard, T. J., Wagener, D. K., Becker, D. J., CAVENDER, D. E., & Drash, A. L. (1984) · Diabetes · doi:10.2337/diab.33.3.271 · Cited by 350 · see citing works

[Etanercept for therapy of rheumatoid arthritis].

Miyasaka, N. (2005) · PubMed · Cited by 345 · see citing works

Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases

Cope, A. P., Gibbons, D. L., Brennan, F. M., Feldmann, M., Aderka, D., Doherty, M., Jones, A. C., Engelmann, H., Wallach, D. S., & Maini, R. N. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1780351008 · Cited by 337 · see citing works

Cutting Edge: Expression of TNFR2 Defines a Maximally Suppressive Subset of Mouse CD4+CD25+FoxP3+ T Regulatory Cells: Applicability to Tumor-Infiltrating T Regulatory Cells

Chen, X., Subleski, J. J., Kopf, H., Howard, O. M. Z., Männel, D. N., & Oppenheim, J. J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.10.6467 · Cited by 336 · see citing works

Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis

Karban, A. S., Okazaki, T., Panhuysen, C. I. M., Gallegos, T. F., Potter, J. J., Wilson, J., Silverberg, M. S., Duerr, R. H., Cho, J. H., Gregersen, P. K., et al. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddh008 · Cited by 335 · see citing works

Autoimmunity associated with anti-tumor necrosis factor α treatment in Crohn’s disease: a prospective cohort study

Vermeire, S., Noman, M., Van Assche, G., Baert, F., Van Steen, K., Esters, N., Joossens, S., Bossuyt, X., & Rutgeerts, P. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00701-7 · Cited by 327 · see citing works

Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis

Diez‐Ruiz, A., Tilz, G. P., Zangerle, R., Baier‐Bitterlich, G., WACHTER, H., & Fuchs, D. (1995) · European Journal Of Haematology · doi:10.1111/j.1600-0609.1995.tb01618.x · Cited by 306 · see citing works

Differentiation of rat marrow mesenchymal stem cells into pancreatic islet beta-cells

Chen, L. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i20.3016 · Cited by 298 · see citing works

Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF-kappaB transcription factors

van Heel, D. A. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.11.1281 · Cited by 296 · see citing works

TNF receptor superfamily‐induced cell death: redox‐dependent execution

Shen, H., & Pervaiz, S. (2006) · The FASEB Journal · doi:10.1096/fj.05-5603rev · Cited by 288 · see citing works

Apoptotic crosstalk of TNF receptors: TNF-R2-induces depletion of TRAF2 and IAP proteins and accelerates TNF-R1-dependent activation of caspase-8

Fotin‐Mleczek, M., Henkler, F., Samel, D., Reichwein, M., Haußer, A., Parmryd, I., Scheurich, P., Schmid, J. A., & Wajant, H. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.13.2757 · Cited by 284 · see citing works

Regulated Commitment of TNF Receptor Signaling

Pimentel‐Muiños, F. X., & Seed, B. (1999) · Immunity · doi:10.1016/s1074-7613(00)80152-1 · Cited by 282 · see citing works

Autoreactive CD8 T cells associated with β cell destruction in type 1 diabetes

Pinkse, G. G. M., Tysma, O. M. H., van Bergen, C. A. M., Kester, M. G. D., OSSENDORP, F. A., van Veelen, P. A., Keymeulen, B., Pipeleers, D., Drijfhout, J. W., & Roep, B. O. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508621102 · Cited by 277 · see citing works

TRAIL/Apo-2-ligand-induced apoptosis in human T cells

Jeremias, I., Herr, I., Böhler, T., & Debatin, K. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199801)28:01 · Cited by 265 · see citing works

Development of glomerulonephritis during anti-TNF-α therapy for rheumatoid arthritis

Stokes, M. B., Foster, K. W., Markowitz, G. S., Ebrahimi, F., Hines, W. H., Kaufman, D., Moore, B., Wolde, D. J., & D’Agati, V. D. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh832 · Cited by 264 · see citing works

Two human TNF receptors have similar extracellular, but distinct intracellular, domain sequences

Dembić, Z., Loetscher, H., Gubler, U., et al. (1990) · Cytokine · doi:10.1016/1043-4666(90)90022-l · Cited by 263 · see citing works

Dermatological conditions during TNF-α-blocking therapy in patients with rheumatoid arthritis: a prospective study

Flendrie, M., Vissers, W. H. P. M., Creemers, M. C. W., et al. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1724 · Cited by 259 · see citing works

Target Depletion of Distinct Tumor Necrosis Factor Receptor Subtypes Reveals Hippocampal Neuron Death and Survival through Different Signal Transduction Pathways

Yang, L., Lindholm, K., Konishi, Y., Li, R., & Shen, Y. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03025.2002 · Cited by 255 · see citing works

Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity.

Gabay, C., Çakır, N., Moral, F., Roux-Lombard, P., Meyer, O., Dayer, J. M., VISCHER, T. L., Yazici, H., & Guerne, P. (1997) · PubMed · Cited by 230 · see citing works

Treatment of patients with new onset type 1 diabetes with a single course of anti-CD3 mAb teplizumab preserves insulin production for up to 5 years

Herold, K. C., Gitelman, S., Greenbaum, C., Puck, J., Hagopian, W., Gottlieb, P., Sayre, P., Bianchine, P., Wong, E., Seyfert-Margolis, V., et al. (2009) · Clinical Immunology · doi:10.1016/j.clim.2009.04.007 · Cited by 219 · see citing works

Linkage of Faulty Major Histocompatibility Complex Class I to Autoimmune Diabetes

Faustman, D. L., Li, X., Lin, H. Y.-F., et al. (1991) · Science · doi:10.1126/science.1763324 · Cited by 214 · see citing works

Human tumor necrosis factor alpha (TNF alpha) mutants with exclusive specificity for the 55-kDa or 75-kDa TNF receptors.

Loetscher, H., Stueber, D., Banner, D. W., Mackay, F., & Lesslauer, W. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74322-1 · Cited by 202 · see citing works

Tumor Necrosis Factor (TNF) Receptor Shedding Controls Thresholds of Innate Immune Activation That Balance Opposing TNF Functions in Infectious and Inflammatory Diseases

Xanthoulea, S., Pasparakis, M., Kousteni, S., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040435 · Cited by 199 · see citing works

NOD2 and Crohn’s Disease: Loss or Gain of Function?

Eckmann, L., & Karin, M. (2005) · Immunity · doi:10.1016/j.immuni.2005.06.004 · Cited by 185 · see citing works

Enhancement of TNF receptor p60-mediated cytotoxicity by TNF receptor p80: requirement of the TNF receptor-associated factor-2 binding site

Weiss, T., Grell, M., Hessabi, B., Bourteele, S., Müller, G., Scheurich, P., & Wajant, H. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.5.2398 · Cited by 184 · see citing works

Recombinant human tumor necrosis factor alpha suppresses autoimmune diabetes in nonobese diabetic mice.

Satoh, J., Seino, H., Abo, T., Tanaka, S., Shintani, S., Ohta, S., Tamura, K., Sawai, T., Nobunaga, T., & Oteki, T. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114304 · Cited by 180 · see citing works

Mechanisms of T regulatory cell function

Askenasy, N., Kaminitz, A., & Yarkoni, S. (2008) · Autoimmunity Reviews · doi:10.1016/j.autrev.2008.03.001 · Cited by 175 · see citing works

Tumor necrosis factor (TNF) receptor expression in T lymphocytes. Differential regulation of the type I TNF receptor during activation of resting and effector T cells

Ware, C. F., Crowe, P. D., VanArsdale, T. L., Andrews, J. L., Grayson, M. H., Jerzy, R., Smith, C. A., & Goodwin, R. G. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.12.4229 · Cited by 174 · see citing works

Anti-tumor necrosis factor-alpha therapy-induced vasculitis: case series.

Jarrett, S. J., Cunnane, G., Conaghan, P. G., Bingham, S. J., Buch, M. H., Quinn, M. A., & Emery, P. (2003) · PubMed · Cited by 174 · see citing works

Infusion of tumor necrosis factor (TNF) causes an increase in circulating TNF-binding protein in humans

Lantz, M., Malik, S., Slevin, M. L., & Olsson, I. (1990) · Cytokine · doi:10.1016/1043-4666(90)90048-x · Cited by 170 · see citing works

Reversal of established autoimmune diabetes by restoration of endogenous β cell function

Ryu, S., Kodama, S., Ryu, K., Schoenfeld, D., & Faustman, D. L. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12335 · Cited by 167 · see citing works

A Dual Role for TNF-α in Type 1 Diabetes: Islet-Specific Expression Abrogates the Ongoing Autoimmune Process When Induced Late but Not Early During Pathogenesis1

Christen, U., Wolfe, T., Möhrle, U., Hughes, A., Rodrigo, E., Green, E. A., Flavell, R., & von Herrath, M. (2001) · Journal of Immunology · doi:10.4049/jimmunol.166.12.7023 · Cited by 161 · see citing works

Monoclonal antibodies specific for murine p55 and p75 tumor necrosis factor receptors: identification of a novel in vivo role for p75.

Sheehan, K. C. F., Pinckard, J. K., Arthur, C. D., Dehner, L. P., Goeddel, D. V., & Schreiber, R. D. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.2.607 · Cited by 158 · see citing works

Local expression of transgene encoded TNF alpha in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells.

Grewal, I. S., Grewal, K. D., Wong, F. S., Picarella, D., Janeway, C. A., & Flavell, R. A. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.5.1963 · Cited by 158 · see citing works

Polymorphisms of the TNF gene and the TNF receptor superfamily member 1B gene are associated with susceptibility to ulcerative colitis and Crohn's disease, respectively

Sashio, H., Tamura, K., Ito, R., et al. (2002) · Immunogenetics · doi:10.1007/s00251-001-0423-7 · Cited by 153 · see citing works

Tumor necrosis factor-α is toxic via receptor 1 and protective via receptor 2 in a murine model of myocardial infarction

Monden, Y., Kubota, T., Inoue, T., et al. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00166.2007 · Cited by 151 · see citing works

TNF Activates a NF-κB–Regulated Cellular Program in Human CD45RA– Regulatory T Cells that Modulates Their Suppressive Function

Nagar, M., Jacob‐Hirsch, J., Vernitsky, H., Berkun, Y., Ben‐Horin, S., Amariglio, N., Bank, I., Kloog, Y., Rechavi, G., & Goldstein, I. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902070 · Cited by 150 · see citing works

Tumour necrosis factor‐α receptor 1 and 2 polymorphisms in inflammatory bowel disease and their association with response to infliximab

Pierik, M. J., Vermeire, S., Steen, K. V., Joossens, S. B. A., Claessens, G., VLIETINCK, R. F., & Rutgeerts, P. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.01946.x · Cited by 149 · see citing works

Analysis of the roles of CD4+ and CD8+ T cells in autoimmune diabetes of NOD mice using transfer to NOD athymic nude mice

Yagi, H., Matsumoto, M., Kunimoto, K., et al. (1992) · European Journal of Immunology · doi:10.1002/eji.1830220931 · Cited by 143 · see citing works

Both tumor necrosis factor receptor types mediate proliferative signals in human mononuclear cell activation

Gehr, G., Gentz, R., Brockhaus, M., Loetscher, H., & Lesslauer, W. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.3.911 · Cited by 142 · see citing works

TNFR80-Dependent Enhancement of TNFR60-Induced Cell Death Is Mediated by TNFR-Associated Factor 2 and Is Specific for TNFR60

Weiß, T., Grell, M., Siemienski, K., Mühlenbeck, F., Dürkop, H., Pfizenmaier, K., Scheurich, P., & Wajant, H. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.6.3136 · Cited by 134 · see citing works

Requirement for TNF-α and IL-1α in Fetal Thymocyte Commitment and Differentiation

Zúñiga‐Pflücker, J. C., Jiang, D., & Lenardo, M. J. (1995) · Science · doi:10.1126/science.7541554 · Cited by 130 · see citing works

NOD Mice Are Defective in Proteasome Production and Activation of NF-κB

Hayashi, T., & Faustman, D. L. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.12.8646 · Cited by 127 · see citing works

A Critical Role of the p75 Tumor Necrosis Factor Receptor (p75TNF-R) in Organ Inflammation Independent of TNF, Lymphotoxin α, or the p55TNF-R

Douni, E. K., & Kollias, G. A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.7.1343 · Cited by 127 · see citing works

Selective death of autoreactive T cells in human diabetes by TNF or TNF receptor 2 agonism

Ban, L., Zhang, J. Y., Wang, L., Kühtreiber, W. M., Burger, D., & Faustman, D. L. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803429105 · Cited by 127 · see citing works

New onset or exacerbation of psoriatic skin lesions in patients with definite rheumatoid arthritis receiving tumour necrosis factor α antagonists

Kary, S., Worm, M., Audring, H., Huscher, D., Renelt, M., Sörensen, H., Ständer, E., Maaß, U., Lee, H., Sterry, W., et al. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.037424 · Cited by 125 · see citing works

Leukocytoclastic vasculitis due to etanercept.

Galaria, N. A., Werth, V. P., & Schumacher, H. R. (2000) · PubMed · Cited by 123 · see citing works

Association of tumor necrosis factor receptor 2 (TNFR2) polymorphism with susceptibility to systemic lupus erythematosus

Komata, T., Tsuchiya, N., Matsushita, M., Hagiwara, K., & Tokunaga, K. (1999) · Tissue Antigens · doi:10.1034/j.1399-0039.1999.530602.x · Cited by 123 · see citing works

PKC Phosphorylation of TRAF2 Mediates IKKα/β Recruitment and K63-Linked Polyubiquitination

Li, S., Wang, L., & Dorf, M. E. (2009) · Molecular Cell · doi:10.1016/j.molcel.2008.11.023 · Cited by 116 · see citing works

Tumor necrosis factor activities and cancer therapy — A perspective

Sidhu, R. S., & Bollon, A. P. (1993) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(93)90037-e · Cited by 114 · see citing works

Function and Regulation of Tumor Necrosis Factor Receptor Type 2

Carpentier, I., Coornaert, B., & Beyaert, R. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043364694 · Cited by 112 · see citing works

Reversal of Diabetes in Non-Obese Diabetic Mice Without Spleen Cell-Derived ß Cell Regeneration

Chong, A. S., Shen, J., Tao, J., et al. (2006) · Science · doi:10.1126/science.1123510 · Cited by 111 · see citing works

Islet Recovery and Reversal of Murine Type 1 Diabetes in the Absence of Any Infused Spleen Cell Contribution

Nishio, J., Gaglia, J. L., Turvey, S. E., et al. (2006) · Science · doi:10.1126/science.1124004 · Cited by 111 · see citing works

IKK-2 is required for TNF-α-induced invasion and proliferation of human mesenchymal stem cells

Böcker, W., Docheva, D., Prall, W. C., Egea, V., Pappou, E. P., Roßmann, O., Popov, C., Mutschler, W., Ries, C., & Schieker, M. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0378-3 · Cited by 107 · see citing works

Psoriasiform Eruption Induced by Infliximab

Verea, M. M., del Pozo, J., Yebra-Pimentel, M. T., Porta, A., & Fonseca, E. (2003) · Annals of Pharmacotherapy · doi:10.1345/aph.1c477 · Cited by 103 · see citing works

Immunological Reversal of Autoimmune Diabetes Without Hematopoietic Replacement of ß Cells

Suri, A., Calderón, B., Esparza, T. J., et al. (2006) · Science · doi:10.1126/science.1123500 · Cited by 101 · see citing works

Inhibition of p75 Tumor Necrosis Factor Receptor by Antisense Oligonucleotides Increases Hypoxic Injury and β-Amyloid Toxicity in Human Neuronal Cell Line

Shen, Y., Li, R., & Shiosaki, K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.6.3550 · Cited by 99 · see citing works

Making regulatory T cells with defined antigen specificity: role in autoimmunity and cancer

Kretschmer, K., Apostolou, I., Jaeckel, E., et al. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00411.x · Cited by 98 · see citing works

The therapeutic potential of tumor necrosis factor for autoimmune disease: a mechanistically based hypothesis

Kodama, S., Davis, M., & Faustman, D. L. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5022-6 · Cited by 96 · see citing works

Control of Receptor-induced Signaling Complex Formation by the Kinetics of Ligand/Receptor Interaction

Krippner‐Heidenreich, A., Tübing, F., Bryde, S., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207399200 · Cited by 94 · see citing works

Association of LMP2 and LMP7 genes within the major histocompatibility complex with insulin-dependent diabetes mellitus: population and family studies.

Deng, G. Y., MUIR, A. B., Maclaren, N. K., et al. (1995) · PubMed · Cited by 88 · see citing works

The Met-196 → Arg Variation of Human Tumor Necrosis Factor Receptor 2 (TNFR2) Affects TNF-α-induced Apoptosis by Impaired NF-κB Signaling and Target Gene Expression

Till, A., Rosenstiel, P. C., Krippner‐Heidenreich, A., Mascheretti-Croucher, S., Croucher, P. J. P., Schäfer, H., Scheurich, P., Seegert, D., & Schreiber, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411541200 · Cited by 86 · see citing works

TNF signaling: early events and phosphorylation.

Ihnatko, R., & Kubes, M. (2007) · PubMed · Cited by 85 · see citing works

Tumor Necrosis Factor for the Treatment of Malignancies

Hieber, U., & Heim, M. (2009) · Oncology · doi:10.1159/000227329 · Cited by 82 · see citing works

Inhibitors in the NFκB cascade comprise prime candidate genes predisposing to multiple sclerosis, especially in selected combinations

Miterski, B., Böhringer, S., Klein, W., Sindern, E., Haupts, M. R., Schimrigk, S., & Epplen, J. T. (2002) · Genes and Immunity · doi:10.1038/sj.gene.6363846 · Cited by 82 · see citing works

Pustular psoriasis induced by infliximab.

Thurber, M., Feasel, A. M., Stroehlein, J., et al. (2004) · PubMed · Cited by 78 · see citing works

Association between tumor necrosis factor receptor II and familial, but not sporadic, rheumatoid arthritis: Evidence for genetic heterogeneity

Dieudé, P., Petit, É., Cailleau‐Moindrault, S., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10101 · Cited by 78 · see citing works

AIMP2 promotes TNFα-dependent apoptosis via ubiquitin-mediated degradation of TRAF2

Choi, J. W., Kim, D. G., Park, M., Um, J. Y., Han, J. M., Park, S. G., Choi, E., & Kim, S. (2009) · Journal of Cell Science · doi:10.1242/jcs.049767 · Cited by 78 · see citing works

Tumour necrosis factor‐related apoptosis‐inducing ligand sequentially activates pro‐survival and pro‐apoptotic pathways in SK‐N‐MC neuronal cells

Milani, D., Zauli, G., Rimondi, E., Celeghini, C., Marmiroli, S., Narducci, P., Capitani, S., & Secchiero, P. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01805.x · Cited by 77 · see citing works

Prevention of diabetes in the BB rat by early immunotherapy using Freund's adjuvant

Sadelain, M., Qin, H.-Y., SUMOSKI, W., Parfrey, N. A., Singh, B., & Rabinovitch, A. (1990) · Journal of Autoimmunity · doi:10.1016/s0896-8411(05)80034-4 · Cited by 77 · see citing works

In vivo apoptosis of diabetogenic T cells in NOD mice by IFN- /TNF-

Qin, H. (2004) · International Immunology · doi:10.1093/intimm/dxh173 · Cited by 75 · see citing works

Structure–Function Relationship of Tumor Necrosis Factor (TNF) and Its Receptor Interaction Based on 3D Structural Analysis of a Fully Active TNFR1-Selective TNF Mutant

Mukai, Y., Shibata, H., Nakamura, T., Yoshioka, Y., Abe, Y., Nomura, T., Taniai, M., Ohta, T., Ikemizu, S., Nakagawa, S., et al. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.11.053 · Cited by 71 · see citing works

Psoriatic lesions induced by antitumour necrosis factor-alpha treatment: two cases

Dereure, O., Guillot, B., Jørgensen, C., Cohen, J.-D., Combes, B., & Guilhou, J. J. (2004) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2004.06107.x · Cited by 71 · see citing works

Essential Role of Human Leukocyte Antigen-encoded Proteasome Subunits in NF-κB Activation and Prevention of Tumor Necrosis Factor-α-induced Apoptosis

Hayashi, T., & Faustman, D. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.7.5238 · Cited by 70 · see citing works

C3-symmetric peptide scaffolds are functional mimetics of trimeric CD40L

Fournel, S., Wieckowski, S., Sun, W., et al. (2005) · Nature Chemical Biology · doi:10.1038/nchembio746 · Cited by 69 · see citing works

Polymorphisms in TNFA and TNFR2 affect outcome of unrelated bone marrow transplantation

Ishikawa, Y., Kashiwase, K., Akaza, T., et al. (2002) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1703409 · Cited by 61 · see citing works

Mechanisms of Sex Differences in TNFR2-Mediated Cardioprotection

Wang, M., Crisostomo, P. R., Markel, T. A., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.756890 · Cited by 60 · see citing works

Expression of the p75 TNF Receptor Is Linked to TNF-Induced NFκB Translocation and Oxyradical Neutralization in Glial Cells

Dopp, J. M., Sarafian, T. A., Spinella, F. M., Kahn, M. A., Shau, H., & de Vellis, J. (2002) · Neurochemical Research · doi:10.1023/a:1021608724117 · Cited by 57 · see citing works

A human tumor necrosis factor p75 receptor agonist stimulates in vitro T cell proliferation but does not produce inflammation or shock in the baboon.

Welborn, M. B., Zee, K. V., Edwards, P. D., Pruitt, J. H., Kaibara, A., Vauthey, J., Rogy, M. A., Castleman, W. L., Lowry, S. F., Kenney, J. S., et al. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.1.165 · Cited by 56 · see citing works

Study of functional variants of the BANK1 gene in rheumatoid arthritis

Orozco, G., Abelson, A.-K., González-Gay, M. Á., et al. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24244 · Cited by 55 · see citing works

Development of type 1 diabetes in a patient treated with anti-TNF-α therapy for active rheumatoid arthritis

Tack, C. J., Kleijwegt, F. S., van Riel, P. L. C. M., & Roep, B. O. (2009) · Diabetologia · doi:10.1007/s00125-009-1381-0 · Cited by 54 · see citing works

Immunoproteasome subunit LMP2 expression is deregulated in Sjögren's syndrome but not in other autoimmune disorders

Krause, S., Kuckelkorn, U., Dörner, T., et al. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.045930 · Cited by 54 · see citing works

TNF Promoter Polymorphisms and Modulation of Growth Retardation and Disease Severity in Pediatric Crohn's Disease

Levine, A., Shamir, R., Wine, E., Weiss, B., Karban, A. S., Shaoul, R. R., Reif, S. S., Yakir, B., Friedlander, M., Kaniel, Y., et al. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.41737.x · Cited by 53 · see citing works

NFκB Polymorphisms and susceptibility to type 1 diabetes

Hegazy, D., O'Reilly, D. D., Yang, B. M., et al. (2001) · Genes and Immunity · doi:10.1038/sj.gene.6363776 · Cited by 51 · see citing works

Cytotoxicity in L929 murine fibrosarcoma cells after triggering of transfected human p75 tumour necrosis factor (TNF) receptor is mediated by endogenous murine TNF

Vercammen, D., Vandenabeele, P., Declercq, W., de Craen, M. V., Grooten, J., & Fiers, W. C. (1995) · Cytokine · doi:10.1006/cyto.1995.0063 · Cited by 48 · see citing works

Reduced expression of Tap1 and Lmp2 antigen-processing genes in the nonobese diabetic (NOD) mouse due to a mutation in their shared bidirectional promoter

Yan, G., Fu, Y., & Faustman, D. L. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.6.3068 · Cited by 47 · see citing works

Tumor Necrosis Factor Receptor 2 (TNFR2) Signaling Is Negatively Regulated by a Novel, Carboxyl-terminal TNFR-associated Factor 2 (TRAF2)-binding Site

Grech, A. P., Gardam, S., Chan, T. D., Quinn, R., Gonzales, R., Basten, A., & Brink, R. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504849200 · Cited by 47 · see citing works

The role of tumor necrosis factor (TNF)-alpha and TNF receptor polymorphisms in susceptibility to ankylosing spondylitis.

Chatzikyriakidou, A., Georgiou, I. A., Voulgari, P. V., et al. (2009) · PubMed · Cited by 41 · see citing works

Reversal of Sjögren's-like syndrome in non-obese diabetic mice

Tran, S. D., Kodama, S., Lodde, B. M., Szalayova, I., Key, S., Khalili, S., Faustman, D. L., & Mezey, É. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.064030 · Cited by 39 · see citing works

Leukemia inhibitory factor is a mediator of Escherichia coli lipopolysaccharide-induced acute thymic atrophy

Sempowski, G. D., Rhein, M. E., Scearce, R. M., & Haynes, B. F. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200211)32:11 · Cited by 38 · see citing works

The primacy of CD8 T lymphocytes in type 1 diabetes and implications for therapies

Faustman, D. L., & Davis, M. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0516-6 · Cited by 38 · see citing works

Reply to 'LMP2 expression and proteasome activity in NOD mice'

Hayashi, T., Kodama, S., & Faustman, D. L. (2000) · Nature Medicine · doi:10.1038/80353 · Cited by 35 · see citing works

Inhibition of the release of soluble tumor necrosis factor receptors in experimental endotoxemia by an anti-tumor necrosis factor-α antibody

Jansen, J., van der Poll, T., Levi, M. M., et al. (1995) · Journal of Clinical Immunology · doi:10.1007/bf01489489 · Cited by 35 · see citing works

Antigen Processing and Autoimmunity: Evaluation of mRNA Abundance and Function of HLA‐linked Genesa

Fu, Y., Yan, G., Shi, L., et al. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb09642.x · Cited by 35 · see citing works

Increased CD8+ T Cell Apoptosis in Scleroderma Is Associated with Low Levels of NF-κB

Kessel, A., Rosner, I., Rozenbaum, M., et al. (2004) · Journal of Clinical Immunology · doi:10.1023/b:joci.0000018060.36183.bb · Cited by 30 · see citing works

Tumor Necrosis Factor Promotes Human T‐Cell Development in Nonobese Diabetic/Severe Combined Immunodeficient Mice

Samira, S., Ferrand, C., Peled, A., et al. (2004) · Stem Cells · doi:10.1634/stemcells.22-6-1085 · Cited by 28 · see citing works

Abnormal class I assembly and peptide presentation in the nonobese diabetic mouse.

Li, F., Guo, J., Fu, Y., et al. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.11128 · Cited by 27 · see citing works

Tumor Necrosis Factor α is Reparative via TNFR1 in the Hippocampus and via TNFR2 in the Striatum after Virus‐Induced Encephalitis

Rodriguez, M., Zoecklein, L. J., Papke, L. M., Gamez, J. D., Đenić, A., Macura, S. I., & Howe, C. L. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00151.x · Cited by 26 · see citing works

Suppression of Death Receptor Signaling in Cerebellar Purkinje Neurons Protects Neighboring Granule Neurons from Apoptosis via an Insulin-like Growth Factor I-dependent Mechanism

Linseman, D. A., McClure, M. L., Bouchard, R. J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201098200 · Cited by 25 · see citing works

Biological Agents for Rheumatoid Arthritis

Klinkhoff, A. (2012) · Drugs · doi:10.2165/00003495-200464120-00001 · Cited by 22 · see citing works

Selected Contribution: Association of gender-related LMP2 inactivation with autoimmune pathogenesis

Hayashi, T., & Faustman, D. L. (2001) · Journal of Applied Physiology · doi:10.1152/jappl.2001.91.6.2804 · Cited by 17 · see citing works

Generation and function of human regulatory CD8+ T cells induced by a humanized OKT3 monoclonal antibody hOKT3γ1(Ala-Ala)

Ablamunits, V. G., & Herold, K. C. (2008) · Human Immunology · doi:10.1016/j.humimm.2008.08.290 · Cited by 16 · see citing works

Abnormal T Lymphocyte Signal Transduction in Systemic Lupus Erythematosus

Kammer, G. M., & Tsokos, G. C. (2001) · KARGER eBooks · doi:10.1159/000060555 · Cited by 15 · see citing works

Crystallization and preliminary X-ray analysis of the tumour necrosis factor α–tumour necrosis factor receptor type 2 complex

Mukai, Y., Nakamura, T., Yoshioka, Y., et al. (2009) · Acta Crystallographica Section F Structural Biology and Crystallization Communications · doi:10.1107/s1744309109004461 · Cited by 15 · see citing works

Relationship of large multifunctional proteasome 7 gene polymorphism with susceptibility to type 1 diabetes mellitus and DR3 gene.

Ding, H., Cheng, H., Fu, Z., et al. (2001) · PubMed · Cited by 14 · see citing works

Immunomodulatory effects of anti-tumor necrosis factor alpha therapy on synovium in spondylarthropathy: histologic findings in eight patients from an open-label pilot study

Warrington (2001) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200101)44:1 · Cited by 2 · see citing works

TNF/TNFR2 signaling in T regulatory (Treg) cells induces a distinctive NF-kB-dependent cellular program that modulate their suppressive capacity (89.27)

Nagar, M., Jacob‐Hirsch, J., Vernitsky, H., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.supp.89.27 · Cited by 1 · see citing works

Untitled work

Shigeyama (2000) · doi:10.1002/1529-0131(200011)43:11

TNF and ROS crosstalk in inflammation

Blaser, H., Dostert, C., Mak, T. W., & Brenner, D. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.12.002 · Cited by 1,008 · see citing works

Regulation of tumour necrosis factor signalling: live or let die

Brenner, D., Blaser, H., & Mak, T. W. (2015) · Nature Reviews Immunology · doi:10.1038/nri3834 · Cited by 998 · see citing works

The TNF Receptor Superfamily in Co-stimulating and Co-inhibitory Responses

Ward-Kavanagh, L. K., Lin, W. W., Šedý, J. R., & Ware, C. F. (2016) · Immunity · doi:10.1016/j.immuni.2016.04.019 · Cited by 463 · see citing works

Glial contributions to neurodegeneration in tauopathies

Leyns, C. E. G., & Holtzman, D. M. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0192-x · Cited by 409 · see citing works

Proinflammatory Signaling Regulates Hematopoietic Stem Cell Emergence

Espín-Palazón, R., Stachura, D. L., Campbell, C. A., García-Moreno, D., Del Cid, N., Kim, A. D., Candel, S., Meseguer, J., Mulero, V., & Traver, D. (2014) · Cell · doi:10.1016/j.cell.2014.10.031 · Cited by 333 · see citing works

Yoga reduces inflammatory signaling in fatigued breast cancer survivors: A randomized controlled trial

Bower, J. E., Greendale, G., Crosswell, A. D., Garet, D., Sternlieb, B., Ganz, P. A., Irwin, M. R., Olmstead, R., Arevalo, J., & Cole, S. W. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.01.019 · Cited by 283 · see citing works

Inflammatory osteolysis: A conspiracy against bone

Mbalaviele, G., Novack, D. V., Schett, G., & Teitelbaum, S. L. (2017) · Journal of Clinical Investigation · doi:10.1172/jci93356 · Cited by 251 · see citing works

Uncoupling the mechanisms of obesity and hypertension by targeting hypothalamic IKK-β and NF-κB

Purkayastha, S., Zhang, G., & Cai, D. (2011) · Nature Medicine · doi:10.1038/nm.2372 · Cited by 220 · see citing works

TNF-driven adaptive response mediates resistance to EGFR inhibition in lung cancer

Gong, K., Guo, G., Gerber, D. E., Gao, B., Peyton, M., Huang, C., Minna, J. D., Hatanpaa, K. J., Kernstine, K., Cai, L., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci96148 · Cited by 98 · see citing works

Diabetes Results from a Late Change in the Autoimmune Response of NOD Mice

Gazda, L. S., Charlton, B., & Lafferty, K. J. (1997) · Journal of Autoimmunity · doi:10.1006/jaut.1997.0138 · Cited by 61 · see citing works

Autoimmunity and Diseases

Alkhatib, A. J. (2022) · Springer eBooks · doi:10.1007/978-981-19-1162-0_5 · Cited by 2 · see citing works

Autoimmunity can benefit self-maintenance

Schwartz, M., & Cohen, I. R. (2000) · Immunology Today · doi:10.1016/s0167-5699(00)01633-9 · Cited by 177 · see citing works

Environmental toxicants and autoimmunity

Mukherjee, S., Mukherjee, S., Dey, C., et al. (2023) · American Journal of Applied Bio-Technology Research · doi:10.15864/ajabtr.342

Think autoimmunity, breath autoimmunity, and learn autoimmunity

Toubi, E., & Vadasz, Z. (2019) · Clinical Rheumatology · doi:10.1007/s10067-019-04540-2 · Cited by 2 · see citing works